$164.16
-0.66-0.40%
At Close: -
$163.87
-0.29-0.18%
After Hours: 5:59 PM EDT
15 minutes delayed
Comments
Loading...
Latest news for Johnson & Johnson (NYSE:JNJ) Stock
Johnson & Johnson Stock (NYSE: JNJ)
Categories: All
Friday, September 20, 2024
- Johnson & Johnson Announced That Its Subsidia...
- Johnson & Johnson's Rybrevant Scores Third FDA-Approval Of 2024 For Certain Type Of Inoperable Lung Cancer In Pretreated Patients
- Zevra Therapeutics' Drug Becomes First FDA-Approved Treatment For Ultra-Rare Neurodegenerative Disease
- RBC Capital Reiterates Outperform on Johnson ...
- Johnson & Johnson Announces FDA Approval Of R...
Thursday, September 19, 2024
Wednesday, September 18, 2024
Monday, September 16, 2024
Thursday, September 12, 2024
- Unpacking the Latest Options Trading Trends in Johnson & Johnson
- Competitor Analysis: Evaluating Johnson & Johnson And Competitors In Pharmaceuticals Industry
- Johnson & Johnson Seeks First EU Approval Of ...
- How To Earn $500 A Month From Johnson & Johnson Stock
- Reported Earlier, FDA Approves Johnson & John...
Wednesday, September 11, 2024
Tuesday, September 10, 2024
Monday, September 09, 2024
Friday, September 06, 2024
Thursday, September 05, 2024
Wednesday, September 04, 2024
Tuesday, September 03, 2024
Friday, August 30, 2024
Thursday, August 29, 2024
- Johnson & Johnson's Golden Cross: A Bullish Prescription For Investors?
- Johnson & Johnson Seeks FDA Approval For Muscle Weakness Drug And Gears Up Showdown With Argenx and UCB
- Competitor Analysis: Evaluating Johnson & Johnson And Competitors In Pharmaceuticals Industry
- Johnson & Johnson Seeks First Approval Of Nip...